Among the “pathways in cancer” that were identified as enriched in the BRD7-binding peaks, we specifically demonstrate that the p53 signaling pathway, which is well known to control cell cycling and proliferation of cancer cells, is functionally regulated by BRD7 in HCC cells. This evidence concerns the gene TP53 and hepatocellular carcinoma.